List of references for fig 1 and fig 2 and for table 1:
1. Bailar JC, MacMahon B (1997) Randomization in the Canadian National Breast Screening Study: a review for evidence of subversion. CMAJ Can Med Assoc J J Assoc Medicale Can 156:193–199.
2. Boyd NF (1997) The review of randomization in the Canadian National Breast Screening Study. Is the debate over? CMAJ Can Med Assoc J J Assoc Medicale Can 156:207–209.
3. Burhenne LJ, Burhenne HJ (1993) The Canadian National Breast Screening Study: a Canadian critique. AJR Am J Roentgenol 161:761–763. doi: 10.2214/ajr.161.4.8372753
4. Kopans DB, Feig SA (1993) The Canadian National Breast Screening Study: a critical review. AJR Am J Roentgenol 161:755–760. doi: 10.2214/ajr.161.4.8372752
5. Miller AB, Wall C, Baines CJ, et al. (2014) Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ 348:g366.
6. Cohen M, Kaufert P, MacWiliam L, Tate R (1997) Checking random assignment with claims data. CMAJ Can Med Assoc J J Assoc Medicale Can 156:1269–1270.
7. Baines CJ, McFarlane DV, Miller AB (1988) Sensitivity and specificity of first screen mammography in 15 NBSS centres. Can Assoc Radiol J J Assoc Can Radiol 39:273–276.
8. Van Zee KJ, Hansen NM, Barrio AV, et al. (2014) Commentary on the canadian national breast screening study. Ann Surg Oncol 21:4397–4398. doi: 10.1245/s10434-014-3789-0
9. Javitt MC (2014) The Canadian National Breast Screening Study: caveat emptor. AJR Am J Roentgenol 202:W505. doi: 10.2214/AJR.14.12722
10. Rijnsburger AJ, van Oortmarssen GJ, Boer R, et al. (2004) Mammography benefit in the Canadian National Breast Screening Study-2: a model evaluation. Int J Cancer J Int Cancer 110:756–762. doi: 10.1002/ijc.20143
11. Kopans DB (1997) Canadian National Breast Screening Study. Lancet 350:810. doi: 10.1016/S0140-6736(05)62600-1
12. Kopans DB (1997) NBSS: opportunity to compromise the process. CMAJ Can Med Assoc J J Assoc Medicale Can 157:247–248.
13. Leitch AM (1995) Controversies in breast cancer screening. Cancer 76:2064–2069.
14. Smart CR, Hendrick RE, Rutledge JH, Smith RA (1995) Benefit of mammography screening in women ages 40 to 49 years. Current evidence from randomized controlled trials. Cancer 75:1619–1626.
15. Tarone RE (1995) The excess of patients with advanced breast cancer in young women screened with mammography in the Canadian National Breast Screening Study. Cancer 75:997–1003.
16. Kotwall CA, Mahoney LJ (1994) Screening mammography: interpretation of the data. Surg Oncol 3:305–307.
17. Mettlin CJ, Smart CR (1993) The Canadian National Breast Screening Study. An appraisal and implications for early detection policy. Cancer 72:1461–1465.
18. Rasuli P (1993) Canadian National Breast Screening Study. CMAJ Can Med Assoc J J Assoc Medicale Can 149:136–137.
19. Warren L (1993) Canadian National Breast Screening Study. CMAJ Can Med Assoc J J Assoc Medicale Can 148:877; author reply 880–883.
20. De Koning HJ (2003) Mammographic screening: evidence from randomised controlled trials. Ann Oncol Off J Eur Soc Med Oncol ESMO 14:1185–1189.
21. Boyd NF, Jong RA, Yaffe MJ, et al. (1993) A critical appraisal of the Canadian National Breast Cancer Screening Study. Radiology 189:661–663. doi: 10.1148/radiology.189.3.8234686
22. Kopans DB (2009) Why the critics of screening mammography are wrong | Diagnostic Imaging. http://www.diagnosticimaging.com/articles/why-critics-screening-mammography-are-wrong. Accessed 15 Jan 2015
23. Freedman DA, Petitti DB, Robins JM (2004) On the efficacy of screening for breast cancer. Int J Epidemiol 33:43–55. doi: 10.1093/ije/dyg275
24. Sickles EA, Kopans DB (1993) Deficiencies in the analysis of breast cancer screening data. J Natl Cancer Inst 85:1621–1624.
25. Moskowitz M (1992) Guidelines for screening for breast cancer. Is a revision in order? Radiol Clin North Am 30:221–233.
26. Miller AB (2004) Commentary: a defence of the Health Insurance Plan (HIP) study and the Canadian National Breast Screening Study (CNBSS). Int J Epidemiol 33:64–65; discussion 69–73. doi: 10.1093/ije/dyh015
27. Merz B (1992) Author of Canadian Breast Cancer Study retracts warnings. J Natl Cancer Inst 84:832–834.
28. Tabar L, Hsiu-Hsi Chen T (2014)We do not want to go back to the dark ages of breast screening. http://www.auntminnie.com/index.aspx?sec=ser&sub=def&pag=dis&ItemID=106498. Accessed 19 Dec 2014
29. Baines CJ (2011) Rational and irrational issues in breast cancer screening. Cancers 3:252–266. doi: 10.3390/cancers3010252
30. Sox H (2002) Screening mammography for younger women: back to basics. Ann Intern Med 137:361–362.
31. Miller AB, To T, Baines CJ, Wall C (2002) The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med 137:305–312.
32. Baines CJ (1997) NBSS: changes were made, suspicious changes were not. CMAJ Can Med Assoc J J Assoc Medicale Can 157:248, 250.
33. Miller AB, To T, Baines CJ, Wall C (1997) The Canadian National Breast Screening Study: update on breast cancer mortality. J Natl Cancer Inst Monogr 37–41.
34. Baines CJ (1995) The Canadian National Breast Screening Study. Why? What next? And so what? Cancer 76:2107–2112.
35. Baines CJ (1994) A different view on what is known about breast screening and the Canadian National Breast Screening Study. Cancer 74:1207–1211.
36. Baines CJ (1994) The Canadian National Breast Screening Study: a perspective on criticisms. Ann Intern Med 120:326–334.
37. Miller AB, Baines CJ, To T, Wall C (1992) Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. CMAJ Can Med Assoc J J Assoc Medicale Can 147:1459–1476.
38. Baines CJ (1992) The Canadian National Breast Screening Study: responses to controversy. Womens Health Issues Off Publ Jacobs Inst Womens Health 2:206–211.
39. Gøtzsche PC, Olsen O (2000) Is screening for breast cancer with mammography justifiable? Lancet 355:129–134. doi: 10.1016/S0140-6736(99)06065-1
40. Miller AB, Baines CJ, To T, Wall C (1993) Mammography. Lancet 341:439.
41. Goel V, Cohen MM, Kaufert P, MacWilliam L (1998) Assessing the extent of contamination in the Canadian National Breast Screening Study. Am J Prev Med 15:206–211.
42. Cohen MM, Kaufert PA, MacWilliam L, Tate RB (1996) Using an alternative data source to examine randomization in the Canadian National Breast Screening Study. J Clin Epidemiol 49:1039–1044.
43. Shapiro S (1994) Screening: assessment of current studies. Cancer 74:231–238.
44. Vainio H, Bianchini F (2002) IARC Handbooks of Cancer Prevention- Breast Cancer Screening. http://www.iarc.fr/en/publications/pdfs-online/prev/handbook7/index.php. Accessed 15 Jan 2014
45. Taubes G (1997) The breast-screening brawl. Science 275:1056–1059.
46. Green BB, Taplin SH (2003) Breast cancer screening controversies. J Am Board Fam Pract Am Board Fam Pract 16:233–241.
47. Cady B (2002) The screening mammography: the continuous dilemma. Breast J 8:185–186.
48. Sun J, Chapman J, Gordon R, et al. (2002) Survival from primary breast cancer after routine clinical use of mammography. Breast J 8:199–208.
49. Kopans DB (1993) Mammography. Lancet 341:957.
50. Yaffe M (1993) Correction: Canada Study (Letter). J Natl Cancer Inst 85:94.
51. Kopans DB The Canadian Screening Program: A Different Perspective : American Journal of Roentgenology: Vol. 155, No. 4 (AJR).
52. Caro JJ, O’Brien JA, Hartz SC (1993) Canadian National Breast Screening Study. CMAJ Can Med Assoc J J Assoc Medicale Can 148:876–877; author reply 880–883.
53. Rose CA (1993) Canadian National Breast Screening Study. CMAJ Can Med Assoc J J Assoc Medicale Can 149:137.
54. Burhenne HJ (1993) Canadian National Breast Screening Study. CMAJ Can Med Assoc J J Assoc Medicale Can 148:875–876; author reply 880–883.
55. Moskowitz M (1992) Response. J Natl Cancer Inst 84:1368–71.
56. Warren L (1992) Response. JNCI J Natl Cancer Inst 84:1366–1367. doi: 10.1093/jnci/84.17.1366
57. Kopans DB (1992) Response. JNCI J Natl Cancer Inst 84:1367–1368. doi: 10.1093/jnci/84.17.1367
58. Stacey-Clear A, McCarthy KA, Hall DA, et al. (1992) Breast cancer survival among women under age 50: is mammography detrimental? Lancet 340:991–994.
59. Miller AB (1993) NBSS revisited–again. Miller comment. J Natl Cancer Inst 85:1771–1776.
60. Basinski AS (1992) The Canadian National Breast Screening Study: opportunity for a rethink. CMAJ Can Med Assoc J J Assoc Medicale Can 147:1431–1434.
61. Baines CJ, Miller AB, Kopans DB, et al. (1990) Canadian National Breast Screening Study: assessment of technical quality by external review. AJR Am J Roentgenol 155:743–747; discussion 748–749. doi: 10.2214/ajr.155.4.2119103
62. Yaffe M, Gordon E, Nishikawa R (1983) Quality assurance in a national breast screening study.
63. Miller AB, Baines CJ, Sickles EA (1990) Canadian National Breast Screening Study. AJR Am J Roentgenol 155:1133–1134. doi: 10.2214/ajr.155.5.2120947
64. Starreveld AA (1992) The Canadian National Breast Screening Study: a clinician’s perspective. CMAJ Can Med Assoc J J Assoc Medicale Can 147:1437–1439.
65. Caines JS, Konok GP, Wright BA (1993) Canadian National Breast Screening Study. Public health implications: a clinician’s perspective. Can J Public Health Rev Can Santé Publique 84:19–20; discussion 21–22.
66. Fletcher SW, Black W, Harris R, et al. (1993) Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst 85:1644–1656.
67. Baines CJ, McFarlane DV, Miller AB (1990) The role of the reference radiologist. Estimates of inter-observer agreement and potential delay in cancer detection in the national breast screening study. Invest Radiol 25:971–976.
68. Pisano ED, McLelland R (1991) Implementation of breast cancer screening. Curr Opin Radiol 3:579–587.
69. Smart CR (1992) Mammographic screening: efficacy and guidelines. Curr Opin Radiol 4:108–117.
70. Shen Y, Yang Y, Inoue LYT, et al. (2005) Role of detection method in predicting breast cancer survival: analysis of randomized screening trials. J Natl Cancer Inst 97:1195–1203. doi: 10.1093/jnci/dji239
71. Baines CJ, Miller AB, Wall C, et al. (1986) Sensitivity and specificity of first screen mammography in the Canadian National Breast Screening Study: a preliminary report from five centers. Radiology 160:295–298. doi: 10.1148/radiology.160.2.3523590
72. Courteau JP, Bouchard F (1993) Canadian National Breast Screening Study. CMAJ Can Med Assoc J J Assoc Medicale Can 148:875; author reply 880–883.
73. Hanley JA, McGregor M, Liu Z, et al. (2013) Measuring the mortality impact of breast cancer
screening. Can J Public Health 104:e437–442
74. Health Quality Ontario (2007) Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis. Ont Health Technol Assess Ser 7:1–32.
75. Narod SA (2001) Re: Canadian national breast screening study-2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst 93:396–397.
76. Miller AB, To T, Baines CJ, Wall C (2000) Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst 92:1490–1499.
77. Miller AB (1994) Mammography screening controversies. Cancer Detect Prev 18:305–311.
78. Burhenne HJ (1993) Canadian National Breast Screening Study. CMAJ Can Med Assoc J J Assoc Medicale Can 149:137–138.
79. Miller AB, Baines CJ, To T, Wall C (1992) Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. CMAJ Can Med Assoc J J Assoc Medicale Can 147:1477–1488.
80. Baines CJ (1984) Impediments to recruitment in the Canadian National Breast Screening Study: response and resolution. Control Clin Trials 5:129–140.
81. Miller AB, Howe GR, Wall C (1981) The National Study of Breast Cancer Screening Protocol for a Canadian Randomized Controlled trial of screening for breast cancer in women. Clin Investig Med Médecine Clin Exp 4:227–258.
82. Fletcher SW (2014) ACP Journal Club. Annual mammography screening did not reduce long-term breast cancer mortality in women 40 to 59 years of age. Ann Intern Med 160:JC7. doi: 10.7326/0003-4819-160-10-201405200-02007
83. Kalager M, Adami H-O, Bretthauer M (2014) Too much mammography. BMJ 348:g1403.
84. Narod SA (1997) On being the right size: a reappraisal of mammography trials in Canada and Sweden. Lancet 349:1846. doi: 10.1016/S0140-6736(05)61736-9
85. Miller AB (1992) Re: “Author of Canadian breast cancer study retracts warnings.” J Natl Cancer Inst 84:1365–1370.
86. Tabár L, Vitak B, Chen TH-H, et al. (2011) Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology 260:658–663. doi: 10.1148/radiol.11110469
87. World Health Organization, geneva (2014) WHO position paper on mammography screening. http://apps.who.int/iris/bitstream/10665/137339/1/9789241507936_eng.pdf?ua=1&ua=1. Accessed 2 Jan 2015
88. Duffy SW, Yen AM-F, Chen TH-H, et al. (2012) Long-term benefits of breast screening.Breast Cancer Manag 1:31–38. doi: 10.2217/bmt.12.8
89. Gøtzsche PC, Jørgensen KJ (2013) Screening for breast cancer with mammography. Cochrane Database Syst Rev 6:CD001877. doi: 10.1002/14651858.CD001877.pub5
90. Health Council of the Netherlands (2014) Population screening for breast cancer: expectations and development. http://gr.nl/sites/default/files/201401epopulation_screening_for_breast_cancer_expectations_and_developments_0.pdf. Accessed 5 Nov 2014
91. Independent UK Panel on Breast Cancer Screening (2012) The benefits and harms of breast cancer screening: an independent review. Lancet 380:1778–1786. doi: 10.1016/S0140-6736(12)61611-0
92. Nelson HD, Tyne K, Naik A, et al. (2009) Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 151:727–737, W237–242. doi: 10.7326/0003-4819-151-10-200911170-00009
93. Nickson C, Mason KE, English DR, Kavanagh AM (2012) Mammographic screening and breast cancer mortality: a case-control study and meta-analysis. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 21:1479–1488. doi: 10.1158/1055-9965.EPI-12-0468
94. Pace LE, Keating NL (2014) A systematic assessment of benefits and risks to guide breast cancer screening decisions. JAMA 311:1327–1335. doi: 10.1001/jama.2014.1398
95. Paci E, EUROSCREEN Working Group (2012) Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet. J Med Screen 19 Suppl 1:5–13. doi: 10.1258/jms.2012.012077
96. Broeders M, Moss S, Nystrom L, et al. (2012) The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. J Med Screen 19:14–25. doi: 10.1258/jms.2012.012078
97. Coldman A, Phillips N, Wilson C, et al. (2014) Pan-Canadian study of mammography screening and mortality from breast cancer. J Natl Cancer Inst. doi: 10.1093/jnci/dju261
98. Hofvind S, Ursin G, Tretli S, et al. (2013) Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program. Cancer 119:3106–3112. doi: 10.1002/cncr.28174
99. Olsen AH, Lynge E, Njor SH, et al. (2013) Breast cancer mortality in Norway after the introduction of mammography screening. Int J Cancer J Int Cancer 132:208–214. doi: 10.1002/ijc.27609
100. Weedon-Fekjær H, Romundstad PR, Vatten LJ (2014) Modern mammography screening and breast cancer mortality: population study. BMJ 348:g3701.